A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...

Two former US Food and Drug Administration (FDA) officials have commented on and proposed changes to the agency’s recent draft guidance on the development of a plausible mechanism framework for ...

Researchers from National Taiwan University break traditional frameworks by unveiling a new symmetry-transition mechanism in ...

Metformin, one of the most widely prescribed treatments for type 2 diabetes for more than 60 years, has long been known to lower blood sugar, yet its exact mechanism has remained only partly ...

Metastases are a key problem in many types of cancer. As descendants of the primary tumor, they can grow in other organs ...

BACKGROUND: Despite antiplatelet therapy, some patients remain at high ischemic risk because of drug nonresponsiveness or high residual platelet reactivity). We aimed to target an orphan platelet GPCR ...

Cell death research has emerged as a cornerstone for understanding the pathogenesis of neurological disorders. Neurons and glial cells in the central ...

Neuroinflammation has emerged as a pivotal area of study over recent decades, propelled by its critical involvement in both ...

While the space has traditionally been dominated by smaller biotechs, that may be changing. The rare disease space has always been uniquely difficult for drug development, but recent regulatory ...

The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing (NGS) methods in nonclinical studies to assess the safety risks associated ...